Skip to main content
. Author manuscript; available in PMC: 2018 May 9.
Published in final edited form as: Cancer. 2015 Aug 26;121(23):4165–4172. doi: 10.1002/cncr.29636

Table 5.

Incidence of adverse events (>10% of all grades), regardless of study drug relationship

Adverse event Grade 3/4
n (%)
All grades
n (%)
Any 30 (60) 50 (100)
Diarrhea 12 (24) 38 (76)
Fatigue 1 (2) 25 (50)
Neuropathy peripheral 2 (4) 14 (28)
Nausea 0 14 (28)
Headache 1 (2) 11 (22)
Constipation 0 9 (18)
Muscular weakness 0 8 (16)
Dehydration 3 (6) 7 (14)
Insomnia 0 7 (14)
Vomiting 0 7 (14)
Convulsion 2 (4) 6 (12)
Edema peripheral 1 (2) 6 (12)
Dyspnea 0 6 (12)
Rash 0 6 (12)